P340 Issues on implementing treat-to-target approach in Asia Pacific, Middle East and Africa: Reality, gaps, and way forward -APMA IBD Coalition
Furkan AKYÜZ(Istanbul University), Rupert W. Leong(The University of Sydney), Byong Duk Ye(University of Ulsan), Hoang Huu Bui(University of Medicine and Pharmacy at Ho Chi Minh City), Emma Flanagan(The University of Melbourne), Alex Hwong‐Ruey Leow(University of Malaya), Shu‐Chen Wei(Kaohsiung Medical University), Susan J. Connor(Liverpool Hospital), Taku Kobayashi(Kanazawa University), Kiran Peddi(Yashoda Hospital), Devendra Desai(P. D. Hinduja Hospital and Medical Research Centre), Chang Hwan Choi(Chung-Ang University), Rabbinu Rangga Pribadi(Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo), WK Leung(Queen Mary Hospital), Kaichun Wu(Xijing Hospital), Zihan Ran(Shanghai University of Medicine and Health Sciences), Yoon‐Kyo An(Mater Hospital), Satimai Aniwan(Chulalongkorn University), Webber Chan(Concord Repatriation General Hospital), Julajak Limsrivilai(Siriraj Hospital), N.A.I. Chopdat(Chris Hani Baragwanath Hospital)
Cited by 0
Related Papers
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
|bioRxiv (Cold Spring Harbor Laboratory)|2021|480